Sigma-Aldrich Insulin Lispro

grade

pharmaceutical primary standard

API family

insulin

form

crystalline powder

manufacturer/tradename

USP

application(s)

USP Biologics
pharmaceutical (small molecule)

format

neat

storage temp.

−20°C

InChI key

WNRQPCUGRUFHED-DETKDSODSA-N

Insulin Lispro is a fast-acting insulin analog created through recombinant DNA methods. It features a reversed sequence of lysine and proline at positions B28 and B29, resulting in rapid onset of action. This insulin analog is employed to manage blood glucose levels around meal times.

The USP biologics proteins category provides critical standards and reference materials necessary for the development and manufacturing of therapeutic proteins. These proteins, which can be naturally derived or genetically engineered, are essential in treating various diseases and conditions, ensuring that they meet quality, safety, and efficacy standards.

The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.

• Insulin Lispro Injection